Cel Sci CVM
NYSE CVM
$1.78 +0.08 (+4.90%)
As of: Sep 29, 2026 · 3:58 PM EDT

Cel Sci (CVM) Operating Expenses (2010 - 2026)

Updated

Cel Sci's Operating Expenses was $5.56 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1.2% from $5.49 million a year earlier and up 4.3% from the prior quarter.

Analysis

Cel Sci (CVM) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Operating Expenses was $22.29 million through Jun 30, 2026, down 10.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $24.81 million, down 5.9% from FY2024.

  • Operating Expenses has now declined for four consecutive fiscal years, with a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
  • In earlier fiscal years, Operating Expenses was $26.35 million in FY2024 (-16.3%), $31.48 million in FY2023 (-12.7%), $36.06 million in FY2022 (-0.4%) and $36.19 million in FY2021 (+22.5%).
  • Quarterly Operating Expenses has moved between $5.33 million (fiscal Q2 2026) and $9.55 million (fiscal Q2 2022) over five years.
  • Compared with a year earlier, Operating Expenses was higher in two of the last eight quarters, with an average decline of 9.8%.
  • The best year-over-year quarter for Operating Expenses over five years was fiscal Q2 2022 (growth of 11.9%); the worst was fiscal Q1 2026 (a decline of 22.1%).
  • Per Business Quant data, CVM's Operating Expenses in the three fiscal quarters before Q3 2026 was $5.33 million (Q2 2026), $5.37 million (Q1 2026) and $6.03 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Cel Sci 3.11 Mn -22.54 Mn - 5.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.56 Mn
Mar 31, 2026 5.33 Mn
Dec 31, 2025 5.37 Mn
Sep 30, 2025 6.03 Mn
Jun 30, 2025 5.49 Mn
Mar 31, 2025 6.39 Mn
Dec 31, 2024 6.89 Mn
Sep 30, 2024 6.12 Mn
Jun 30, 2024 6.67 Mn
Mar 31, 2024 7.08 Mn
Dec 31, 2023 6.49 Mn
Sep 30, 2023 7.47 Mn
Jun 30, 2023 8.18 Mn
Mar 31, 2023 8.18 Mn
Dec 31, 2022 7.65 Mn
Sep 30, 2022 8.95 Mn
Jun 30, 2022 8.72 Mn
Mar 31, 2022 9.55 Mn
Dec 31, 2021 8.84 Mn
Sep 30, 2021 8.47 Mn
API Access

Cel Sci Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CVM&period=max&api_key=YOUR_API_KEY